Warby Parker Inc.
Company Information
Industry Ophthalmic Goods
SIC Code 3851
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 233 SPRING STREET, NEW YORK, NY, 10013
Mailing Address 233 SPRING STREET, NEW YORK, NY, 10013
Phone (646) 847-7215
Fiscal Year End 1231
EIN 800423634
Financial Overview
FY2024
-$20.39M
Net Income
$336.42M
Total Liabilities
$340.07M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 12, 2026 | View on SEC |
| 3 Initial insider ownership report | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
Insider Trading
STRONG SELL 5 insiders
15 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 3851)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.